HealthcareServices

Global Cannabis Use Disorder Market Forecast 2026–2035: Long-Term Growth Insights

February 20, 2026February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the cannabis use disorder market from 2026–2035 with trusted insights from The Business Research Company

How is the Cannabis Use Disorder Market size predicted to change over the forecast window of 2026–2035?

The cannabis use disorder market size has experienced strong growth over recent years. It is projected to expand from $1.65 billion in 2025 to $1.78 billion in 2026, displaying a compound annual growth rate (CAGR) of 7.5%. This historical growth can be attributed to the increasing prevalence of cannabis consumption, rising awareness of substance use disorders, the expansion of rehabilitation infrastructure, a greater recognition of mental health disorders, and the availability of behavioral therapy frameworks.

The cannabis use disorder market is poised for significant expansion in the upcoming years, with projections indicating it will reach $2.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.3%. This expected growth during the forecast period is fueled by several factors, such as the increasing acceptance of digital mental health solutions, rising investments in addiction research, the broadening of telehealth-based treatment models, a growing emphasis on outcome-based care, and the increasing integration of pharmacotherapy and behavioral therapy. Furthermore, major trends anticipated in this period encompass the greater adoption of integrated behavioral and pharmacological treatments, an escalating focus on personalized addiction therapy programs, the expanding utilization of digital therapeutics and remote monitoring, the wider implementation of multidisciplinary treatment approaches, and an enhanced emphasis on early diagnosis and intervention.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21126&type=smp

Which Drivers Are Contributing To The Expansion Of The Cannabis Use Disorder Market?

The expanding recognition and identification of cannabis addiction are projected to drive the future expansion of the cannabis use disorder market. This awareness and diagnosis entail informing the general public, medical practitioners, and affected individuals about the indications, manifestations, and dangers associated with cannabis use disorder (CUD). The heightened awareness and diagnostic rates for cannabis addiction stem from various elements, including the increased legalization and accessibility of cannabis, alongside its growing acceptance within scientific and medical communities. Treatment for cannabis use disorder, which provides a systematic method for handling withdrawal symptoms, diminishing cravings, and tackling underlying psychological issues, directly supports the diagnosis of cannabis addiction. It achieves this by supplying clinical proof of dependency habits, emphasizing the disorder’s gravity, and directing suitable intervention levels tailored to each person’s unique requirements. As an illustration, data from November 2024, provided by The Office for Health Improvement and Disparities, a UK-based government agency, showed that the proportion of new patients seeking help for cannabis-related problems stayed relatively consistent this year, seeing a marginal increase of 0.5 percentage points, moving from 20.9% to 21.4%. Concurrently, the count of new individuals with benzodiazepine-related issues increased from 3,620 in 2022–2023 to 3,872 in the current year. Consequently, the expanding awareness and diagnosis of cannabis addiction are propelling the expansion of the cannabis use disorder market.

What Segment Categories Are Covered In The Cannabis Use Disorder Market?

The cannabis use disorder market covered in this report is segmented –

1) By Treatment: Pharmacotherapy, Behavioral Therapies

2) By Route Of Administration: Oral, Transdermal, Inhalation, Sublingual

3) By End-User: Hospitals, Specialty Clinics, Rehabilitation Centers

Subsegments:

1) By Pharmacotherapy: Cannabinoid-Based Medications, Antidepressants, Anxiolytics (Non-Benzodiazepine), Antipsychotics

2) By Behavioral Therapies: Cognitive Behavioral Therapy (CBT), Contingency Management, Motivational Enhancement Therapy (MET), 12-Step Facilitation Therapy

Which Trends Are Expected To Influence The Cannabis Use Disorder Market In The Upcoming Years?

Major companies operating in the cannabis use disorder (CUD) market are focusing on creating advanced solutions, including digital therapeutics and technology-enabled behavioral intervention platforms, to assist individuals in reducing or stopping problematic cannabis use via structured counseling, personalized care pathways, and continuous support. Digital therapeutics in CUD treatment refer to clinically validated, technology-driven programs that deliver behavioral therapies, monitor progress, and provide remote access to licensed clinicians to enhance adherence and long-term recovery outcomes. For instance, in April 2024, Pelago, a US-based virtual clinic specializing in substance use management, launched a cannabis use disorder (CUD) treatment program designed to address the increasing number of individuals affected by the condition, estimated at nearly 18 million adults in the U.S. Pelago’s program offers education on cannabis use and provides evidence-based therapies such as cognitive behavioral therapy and motivational enhancement therapy, while also extending support to adolescents aged 15-17 years through abstinence-focused treatment goals.

Which Major Industry Participants Are Leading The Cannabis Use Disorder Market Growth?

Major companies operating in the cannabis use disorder market are Lyra Health Inc., Pyramid Healthcare Inc., Hazelden Betty Ford Foundation, Charlie Health, Caron Treatment Center, Promises Behavioral Health, Sierra Tucson, Samarpan, Affect Therapeutics Inc., Cadabam’s Rehabilitation Center, Aelis Farma, Skywood Recovery, Pelago, PleoPharma Inc., Abhasa, Marijuana Anonymous, Northpoint Colorado, Sukoon Health, Granite Mountain Behavioral Healthcare, GreeneStone

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/cannabis-use-disorder-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Cannabis Use Disorder Market?

North America was the largest region in the cannabis use disorder market in 2025. The regions covered in the cannabis use disorder market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Cannabis Use Disorder Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21126&type=smp

Browse Through More Reports Similar to the Global Cannabis Use Disorder Market 2026, By The Business Research Company

Cannabis Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabis-testing-global-market-report

Cannabinoids Market Report 2026

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

Medical Marijuana Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-marijuana-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795